DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	TJP1; TEAD4; TEAD3; WWTR1; AMOTL2;	GO:0035329~hippo signaling	5	27	18.5185185185185	0.00010120556846149	0.00327213627744262	0.279327368953721	0.288132253409871	0.213082872626187	0.279327368953721	0.0279159438985224
down	RHOD; SHROOM2; BAIAP2; AIF1L; PLS3; BAIAP2L2;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.00010519820050713	0.00327213627744262	0.290241835199198	0.299499276843826	0.217561706080316	0.290241835199198	0.0279159438985224
down	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00010796677706925	0.00327213627744262	0.297772371157011	0.307381414316175	0.220684092329562	0.297448470825804	0.0279159438985224
down	TAL1; SOX9; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00010796677706925	0.00327213627744262	0.297772371157011	0.307381414316175	0.220684092329562	0.297448470825804	0.0279159438985224
down	BMP7; WNT5A; SULF1;	GO:0060686~negative regulation of prostatic bud formation	3	4	75	0.00010796677706925	0.00327213627744262	0.297772371157011	0.307381414316175	0.220684092329562	0.297448470825804	0.0279159438985224
down	ANXA8; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00010796677706925	0.00327213627744262	0.297772371157011	0.307381414316175	0.220684092329562	0.297448470825804	0.0279159438985224
down	MAOA; SLA; GRAP; GRB7; SHB; FCRL2; SH2D4A;	GO:0009967~positive regulation of signal transduction	7	67	10.4477611940298	0.00011521315514095	0.00345275634406641	0.317181816103059	0.328011852686309	0.228861259569647	0.317181816103059	0.029456888168349
down	GHR; FGFR3; FLT3; PTK6; IL18; HES1; STAP2;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	7	69	10.1449275362319	0.00013644268791768	0.00396454947526903	0.375353834461542	0.38845233250164	0.252820139463675	0.375288403085705	0.0338232064163982
down	NFASC; ITGAD; LILRB2; PERP; PARVA;	GO:0034113~heterotypic cell-cell adhesion	5	29	17.2413793103448	0.00013646851021298	0.00396454947526903	0.375353834461542	0.388525848576365	0.252820139463675	0.375288403085705	0.0338232064163982
up	S100A8; CARD18; S100A12; NLRP10;	GO:0006954~inflammatory response	4	381	1.0498687664042	0.00014778503204582	0.00421187341330592	0.0326604920821266	0.0336949873064474	0.029852576473256	0.0326604920821266	0.0253081056316256
down	NLRP6; TYRO3; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	4	15	26.6666666666667	0.00015435673590169	0.00435102601101115	0.424172310257858	0.439453627112126	0.271204784979278	0.424017953521956	0.0371203971123507
down	COBL; EPS8L1; P2RY12; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	4	15	26.6666666666667	0.00015435673590169	0.00435102601101115	0.424172310257858	0.439453627112126	0.271204784979278	0.424017953521956	0.0371203971123507
down	PTN; MDK; TRIP13; HORMAD1; PAQR5;	GO:0048477~oogenesis	5	30	16.6666666666667	0.00015728156030336	0.00439000590376166	0.43189516459305	0.44778060218369	0.273984478048468	0.43189516459305	0.0374529506513629
down	P2RY1; P2RX1; P2RY12;	GO:0043270~positive regulation of ion transport	3	5	60	0.00017084245723353	0.00467681226676797	0.468962545106049	0.486388475743869	0.286231590628454	0.468791702648815	0.0398998140031793
down	LMNA; PTN; WNT5A;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.00017084245723353	0.00467681226676797	0.468962545106049	0.486388475743869	0.286231590628454	0.468791702648815	0.0398998140031793
down	BTC; SOX9; BCAR1; GRB7; FAM83A; GAREM1;	GO:0007173~epidermal growth factor receptor signaling pathway	6	50	12	0.00017815297955459	0.0047849201206785	0.488673622918243	0.507201532791921	0.292527192428639	0.488495469938689	0.0408221266848243
down	TMEM132D; DLG2; SH3RF2; PKMYT1; SH2D4A; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	6	50	12	0.00017815297955459	0.0047849201206785	0.488673622918243	0.507201532791921	0.292527192428639	0.488495469938689	0.0408221266848243
down	ERBB2; ERBB3; BTC; PTK6; GRB7;	GO:0038128~ERBB2 signaling pathway	5	31	16.1290322580645	0.00018043432781911	0.00480090216169171	0.494570492552187	0.513696531301013	0.294444007692382	0.494570492552187	0.0409584760671481
down	CCL24; FLT4; WNT5A; CAV2; ECM1; CCL26; NRARP;	GO:0001938~positive regulation of endothelial cell proliferation	7	73	9.58904109589041	0.00018841654576706	0.00496686949813741	0.516261335401764	0.53642190579884	0.300712807044239	0.516261335401764	0.0423744118535471
down	FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	4	16	25	0.00019068961956192	0.00498067290727336	0.522298867980108	0.542893346892796	0.302573106358135	0.522298867980108	0.0424921744289337
down	EPHA2; BCAR1; CX3CL1; ARHGEF16; CCR5; CXCR1; CCR2;	GO:0060326~cell chemotaxis	7	74	9.45945945945946	0.00020363156358871	0.00527035510488242	0.557543221105897	0.579739061537066	0.311112107807295	0.557543221105897	0.0449635727116408
down	TRPM2; CXCR1; CCR2; CCR5;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.00023280455977148	0.00589524095315786	0.637186080094547	0.66279458166941	0.328665579393165	0.637186080094547	0.0502947315645574
down	EDN2; NCKAP1L; CXADR; CX3CL1; CXCR1; CCL26; CCL24;	GO:0030593~neutrophil chemotaxis	7	76	9.21052631578947	0.00023703452242607	0.00589524095315786	0.648526453357732	0.674837285347026	0.331137227829222	0.648526453357732	0.0502947315645574
down	NCR1; MNDA; CCR2; CCR5; LILRB2; IL1RL2;	GO:0006968~cellular defense response	6	53	11.3207547169811	0.00023812880562457	0.00589524095315786	0.651282283383202	0.677952709613154	0.331850241361918	0.650806025771953	0.0502947315645574
down	PARD3; PARVA; PARD6G; RHOD; PARVG; RHOV;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.00023812880562457	0.00589524095315786	0.651282283383202	0.677952709613154	0.331850241361918	0.650806025771953	0.0502947315645574
down	CCR2; BDKRB1; P2RY1; NMU; DLG2; NDN;	GO:0019233~sensory perception of pain	6	53	11.3207547169811	0.00023812880562457	0.00589524095315786	0.651282283383202	0.677952709613154	0.331850241361918	0.650806025771953	0.0502947315645574
down	OVOL1; FBLN1; KDF1;	GO:2000647~negative regulation of stem cell proliferation	3	6	50	0.00025344069465549	0.00618793411836576	0.692399977798808	0.72154565768419	0.341096034174426	0.692399977798808	0.0527918176534689
down	EPS8L1; CNKSR1; RTKN; EPS8L2; RHOD; RHOV; C15orf62;	GO:0007266~Rho protein signal transduction	7	77	9.09090909090909	0.00025531529286104	0.00618793411836576	0.697266064803519	0.726882638775401	0.34212820996202	0.697266064803519	0.0527918176534689
down	ANXA1; WNT5A; CCR2; NLRP6; DUOXA1; MGLL; IL1RL2;	GO:0050727~regulation of inflammatory response	7	78	8.97435897435897	0.00027471294532444	0.00651756462782234	0.749416914845073	0.782107755338681	0.353830273577879	0.749416914845073	0.0556040314578472
down	CCR2; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	4	18	22.2222222222222	0.00028121489818677	0.00661668442262606	0.76687302735534	0.800618815137754	0.357424135595393	0.76687302735534	0.0564496633008878
down	TRIM16; ORM2; WNT5A; LILRA2; TLR8;	GO:0050718~positive regulation of interleukin-1 beta secretion	5	35	14.2857142857143	0.00029994409913958	0.0069995151659868	0.8176476142545	0.85394085025039	0.367131577346848	0.8176476142545	0.0597157502386362
down	ANXA1; PDLIM4; CXADR; GPR65; PARVA; PARVG;	GO:0031532~actin cytoskeleton reorganization	6	56	10.7142857142857	0.00031294492985967	0.00724353020577629	0.852774933867603	0.890954215310483	0.373912836897084	0.852774933867603	0.0617975431664304
down	TERT; HHEX; KANK1; SULF1; ATP6V1C2;	GO:0030177~positive regulation of Wnt signaling pathway	5	36	13.8888888888889	0.00033746770082299	0.00771844175641137	0.919262017041827	0.960770544243055	0.384928870643832	0.919262017041827	0.0658492094419716
down	FCGR2B; FLT4; SLAMF1; TPD52L1; SH3RF2; TLR9; TNFRSF19;	GO:0046330~positive regulation of JNK cascade	7	81	8.64197530864197	0.00034010984800292	0.00771844175641137	0.926119116111959	0.968292737264322	0.385935612757051	0.926119116111959	0.0658492094419716
down	CEACAM4; ANXA1; ICAM3; IRF8; SLAMF1; TYRO3;	GO:0006909~phagocytosis	6	57	10.5263157894737	0.00034159594706983	0.00771844175641137	0.929824167924103	0.972523661307833	0.386444984263342	0.929824167924103	0.0658492094419716
down	ALOX15B; PRLR; CD24;	GO:0030856~regulation of epithelial cell differentiation	3	7	42.8571428571429	0.00035807268604348	0.00790258090826207	0.974315778724328	1	0.39270129262533	0.973599633352241	0.0674201764790179
down	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00035807268604348	0.00790258090826207	0.974315778724328	1	0.39270129262533	0.973599633352241	0.0674201764790179
down	SOX9; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	3	7	42.8571428571429	0.00035807268604348	0.00790258090826207	0.974315778724328	1	0.39270129262533	0.973599633352241	0.0674201764790179
up	PIGR; S100A8; S100A11; S100A12;	GO:0043312~neutrophil degranulation	4	483	0.82815734989648	0.00036074208345948	0.00822491950287629	0.0790025162776276	0.0822491950287629	0.0567752180090352	0.0790025162776276	0.0494215070502385
down	TERT; MDK; ERBB3; TYRO3; NAIP; NTRK2; UNC5B; LGMN; FOXQ1;	GO:0043524~negative regulation of neuron apoptotic process	9	138	6.52173913043478	0.00036517848680262	0.00799740886097737	0.992555127129521	1	0.395377503850996	0.980596180369174	0.0682291928473952
down	BMP7; WNT5A; SOX9; PRRX1; PITX1; SULF1;	GO:0051216~cartilage development	6	58	10.3448275862069	0.00037225915899519	0.00809024294396421	1	1	0.397959377389672	0.980596180369174	0.069021198690916
down	DKK1; SOX9; APCDD1; TNFRSF19; SOX21;	GO:0001942~hair follicle development	5	37	13.5135135135135	0.00037843589759134	0.00816217424577696	1	1	0.400385179651643	0.980596180369174	0.0696348742886579
down	PTN; MDK; LTK; WNT5A; CX3CL1; PTK6; NTRK2; NDRG4;	GO:0010976~positive regulation of neuron projection development	8	111	7.20720720720721	0.00041152950081246	0.00880920668280525	1	1	0.412764089314906	0.980596180369174	0.0751549748227112
down	HS3ST1; SDC1; SDC4; GALNT5; HS6ST2;	GO:0006024~glycosaminoglycan biosynthetic process	5	38	13.1578947368421	0.00042305004859233	0.00898823498762964	1	1	0.41712734791204	0.980596180369174	0.0766823391162397
down	NCKAP1L; SPNS2; TNFRSF13B; GAPT;	GO:0001782~B cell homeostasis	4	21	19.047619047619	0.00046948341147889	0.00965759686661942	1	1	0.43473723803644	0.980596180369174	0.0823929413275548
down	PLPP3; PLPP2; FUT3; FUT6;	GO:0006672~ceramide metabolic process	4	21	19.047619047619	0.00046948341147889	0.00965759686661942	1	1	0.43473723803644	0.980596180369174	0.0823929413275548
down	CXADR; TJP1; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.00046948341147889	0.00965759686661942	1	1	0.43473723803644	0.980596180369174	0.0823929413275548
down	GPR157; GPR65; P2RY10; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.00047151596925187	0.00965759686661942	1	1	0.435384380465553	0.980596180369174	0.0823929413275548
up	S100A8; S100A12; WFDC12;	GO:0042742~defense response to bacterium	3	216	1.38888888888889	0.00048026902956044	0.00995466715816191	0.104698648444177	0.109501338739781	0.0662771260793411	0.104698648444177	0.0598151328979975
down	IL18RAP; IL18; LILRA2;	GO:0032635~interleukin-6 production	3	8	37.5	0.00048693432177493	0.0096944196789737	1	1	0.441162495528091	0.980596180369174	0.0827070919242015
down	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.00048693432177493	0.0096944196789737	1	1	0.441162495528091	0.980596180369174	0.0827070919242015
down	SULT2B1; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	3	8	37.5	0.00048693432177493	0.0096944196789737	1	1	0.441162495528091	0.980596180369174	0.0827070919242015
down	TERT; PTN; HES1;	GO:0060253~negative regulation of glial cell proliferation	3	8	37.5	0.00048693432177493	0.0096944196789737	1	1	0.441162495528091	0.980596180369174	0.0827070919242015
down	ALOX15B; CDH1; PTN; IGFBP5; CX3CL1; KANK1; SULF1; LIMCH1;	GO:0030336~negative regulation of cell migration	8	116	6.89655172413793	0.00054171254964163	0.0107101085335399	1	1	0.461295158531221	0.980596180369174	0.0913723523774074
down	DCN; PTN; EPHA2; CCR2; HHEX; SULF1; STAB1;	GO:0016525~negative regulation of angiogenesis	7	89	7.86516853932584	0.00057691153980232	0.0112497750261454	1	1	0.472490551098106	0.980596180369174	0.0959764697655933
down	LMNA; FUT3; PHLDA2; AJUBA; CAMSAP3; RHOD; AMOTL2;	GO:0030334~regulation of cell migration	7	89	7.86516853932584	0.00057691153980232	0.0112497750261454	1	1	0.472490551098106	0.980596180369174	0.0959764697655933
down	EML1; MID1; NEFH; MARK1; CAMSAP3; PARD3; TACC2; TUBB6;	GO:0000226~microtubule cytoskeleton organization	8	118	6.77966101694915	0.00060230745094891	0.0116206963759333	1	1	0.4804629954616	0.980596180369174	0.0991409527557508
down	FLT4; NCKAP1L; BCAR1; SHB; SULF1; BAIAP2;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	6	64	9.375	0.00060409661525751	0.0116206963759333	1	1	0.480860905744978	0.980596180369174	0.0991409527557508
down	FOXP2; WNT5A; SOX9; PRRX1;	GO:0002053~positive regulation of mesenchymal cell proliferation	4	23	17.3913043478261	0.00063624421412578	0.011870690583014	1	1	0.490891004067872	0.980596180369174	0.101273756425308
down	SPTA1; BAIAP2L2; A4GALT; BAIAP2;	GO:0007009~plasma membrane organization	4	23	17.3913043478261	0.00063624421412578	0.011870690583014	1	1	0.490891004067872	0.980596180369174	0.101273756425308
down	IL2RA; IGFBP2; CD24; IL18;	GO:0042104~positive regulation of activated T cell proliferation	4	23	17.3913043478261	0.00063624421412578	0.011870690583014	1	1	0.490891004067872	0.980596180369174	0.101273756425308
down	PTN; MDK; IL34; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	4	23	17.3913043478261	0.00063624421412578	0.011870690583014	1	1	0.490891004067872	0.980596180369174	0.101273756425308
down	SFN; KDF1; EXPH5;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.0006421097119017	0.011870690583014	1	1	0.492050729878655	0.980596180369174	0.101273756425308
down	MATN2; P2RY1; NDN;	GO:0008347~glial cell migration	3	9	33.3333333333333	0.0006421097119017	0.011870690583014	1	1	0.492050729878655	0.980596180369174	0.101273756425308
down	TJP1; CDH1; CDH3; PKP3; CDH26;	GO:0007043~cell-cell junction assembly	5	43	11.6279069767442	0.00070815925544431	0.0129239064118588	1	1	0.505152272230809	0.980596180369174	0.110259174970909
down	IL2RA; SDC4; IL20RB; LILRB2; LILRB1;	GO:0042130~negative regulation of T cell proliferation	5	43	11.6279069767442	0.00070815925544431	0.0129239064118588	1	1	0.505152272230809	0.980596180369174	0.110259174970909
down	SOX9; IL18; SOSTDC1; CMTM5;	GO:0045662~negative regulation of myoblast differentiation	4	24	16.6666666666667	0.00073364018085109	0.0131363119175035	1	1	0.509968850182191	0.980596180369174	0.112071293928237
down	WNT5A; SOX9; TIFAB; GRHL3;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.00073364018085109	0.0131363119175035	1	1	0.509968850182191	0.980596180369174	0.112071293928237
down	CLDN4; ANXA1; KANK1; DUOX1;	GO:0090303~positive regulation of wound healing	4	24	16.6666666666667	0.00073364018085109	0.0131363119175035	1	1	0.509968850182191	0.980596180369174	0.112071293928237
down	IL18RAP; CD40LG; WNT5A; RIPK4; CX3CL1; IL18; RAB7B; CARD14; TLR9;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	9	154	5.84415584415584	0.00077072523342847	0.0136289114259059	1	1	0.517156631630504	0.980596180369174	0.116273863465393
down	ANXA1; CCR2; CCL26; CX3CL1; CCL24;	GO:0002548~monocyte chemotaxis	5	44	11.3636363636364	0.00077911419953058	0.0136922106547134	1	1	0.518807693229813	0.980596180369174	0.116813895288758
down	TFAP2A; MUC1; HHEX;	GO:0010944~negative regulation of transcription by competitive promoter binding	3	10	30	0.00082557462376597	0.0143317741089131	1	1	0.527542184586461	0.980596180369174	0.122270274850351
down	ALOX15B; SOX9; ANXA1;	GO:0030850~prostate gland development	3	10	30	0.00082557462376597	0.0143317741089131	1	1	0.527542184586461	0.980596180369174	0.122270274850351
down	IL2RA; IL20RB; IL36A; IL1RN;	GO:0002437~inflammatory response to antigenic stimulus	4	25	16	0.00084111665146768	0.0145130854953243	1	1	0.530643037992444	0.980596180369174	0.12381711705436
down	AJUBA; PCDHGC3; CDH1; CDH26; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	5	45	11.1111111111111	0.00085523889726069	0.0145800307814442	1	1	0.533239707166693	0.980596180369174	0.124388254896167
down	IGFBP5; KLF5; IL18; PLA2G4F; P2RY13;	GO:0071407~cellular response to organic cyclic compound	5	45	11.1111111111111	0.00085523889726069	0.0145800307814442	1	1	0.533239707166693	0.980596180369174	0.124388254896167
down	KANK1; TRIP10; ABLIM2; SHROOM2; PDLIM4; AMOTL2; CSRP2; SHROOM3; RHOV;	GO:0030036~actin cytoskeleton organization	9	157	5.73248407643312	0.00087716342166499	0.0146976580162438	1	1	0.53699824046894	0.980596180369174	0.125391781341639
down	PLPP3; ITGB5; PTN; FBLN1; CD40LG; BCAR1; ITGAD;	GO:0007229~integrin-mediated signaling pathway	7	96	7.29166666666667	0.00087762622506548	0.0146976580162438	1	1	0.537107249740078	0.980596180369174	0.125391781341639
down	WNT5A; IRF8; GBP6; RAB7B; CX3CL1; CCL24; CCL26;	GO:0071346~cellular response to interferon-gamma	7	96	7.29166666666667	0.00087762622506548	0.0146976580162438	1	1	0.537107249740078	0.980596180369174	0.125391781341639
down	CXCR1; CCR2; CCR5; CX3CL1; CCL26; CCL24;	GO:0070098~chemokine-mediated signaling pathway	6	70	8.57142857142857	0.00093479331107249	0.0153274145159464	1	1	0.545700006410198	0.980596180369174	0.130764493730369
down	DKK1; TRIM16; IGFBP2; GJB2; AQP3;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.00093676505998407	0.0153274145159464	1	1	0.546020808841212	0.980596180369174	0.130764493730369
down	GJB6; GJB2; SOX2; KCNQ1; TIFAB;	GO:0048839~inner ear development	5	46	10.8695652173913	0.00093676505998407	0.0153274145159464	1	1	0.546020808841212	0.980596180369174	0.130764493730369
down	DKK1; NXN; SOSTDC1; APCDD1; TSKU;	GO:0030178~negative regulation of Wnt signaling pathway	5	47	10.6382978723404	0.00102392731575407	0.0165285023845891	1	1	0.559026640395803	0.980596180369174	0.141011469624793
down	TAL1; PTN; MDK; BTC; GAREM1;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.00102392731575407	0.0165285023845891	1	1	0.559026640395803	0.980596180369174	0.141011469624793
down	FUT3; FUT2; FUT6;	GO:0036065~fucosylation	3	11	27.2727272727273	0.00103919983380452	0.0165285023845891	1	1	0.561167910254439	0.980596180369174	0.141011469624793
down	ITGB5; PLEKHA7; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	3	11	27.2727272727273	0.00103919983380452	0.0165285023845891	1	1	0.561167910254439	0.980596180369174	0.141011469624793
down	WNT5A; FOXA1; TJP1;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	3	11	27.2727272727273	0.00103919983380452	0.0165285023845891	1	1	0.561167910254439	0.980596180369174	0.141011469624793
down	ANXA1; HSPB1; MT1G; FLT4;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	4	27	14.8148148148148	0.00108852983090091	0.0170625492371551	1	1	0.568408358171343	0.980596180369174	0.145567643546457
down	PLEKHA7; CDH26; CDH3; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	4	27	14.8148148148148	0.00108852983090091	0.0170625492371551	1	1	0.568408358171343	0.980596180369174	0.145567643546457
down	ALOX15B; IL1RN; ALDH3B2; PLTP; MGLL; ANGPTL4; EPHX3; LIPG;	GO:0006629~lipid metabolic process	8	130	6.15384615384615	0.00109075657223823	0.0170625492371551	1	1	0.568842504570328	0.980596180369174	0.145567643546457
down	EPHB3; TYRO3; PARVA; LAMC3; PARVG;	GO:0034446~substrate adhesion-dependent cell spreading	5	48	10.4166666666667	0.00111696301016595	0.0173264076435805	1	1	0.572715194657891	0.980596180369174	0.147818728417739
down	CRYAB; CD24; EDNRA; ALDH3A1; POSTN; PLEKHN1; AJUBA; EPAS1; ANGPTL4;	GO:0001666~response to hypoxia	9	163	5.52147239263804	0.00112588177522388	0.0173264076435805	1	1	0.573994974724877	0.980596180369174	0.147818728417739
down	CSF3; WNT5A; CCR5; IRF8; LILRB2; LILRB1; PLSCR4; CD180; IL36A;	GO:0071222~cellular response to lipopolysaccharide	9	163	5.52147239263804	0.00112588177522388	0.0173264076435805	1	1	0.573994974724877	0.980596180369174	0.147818728417739
down	CCL24; TERT; HSPB1; JUP; WNT5A; CX3CL1; ECM1; ANGPTL4;	GO:0045766~positive regulation of angiogenesis	8	131	6.10687022900763	0.00114262904800921	0.0174895962348507	1	1	0.576174819893919	0.980596180369174	0.149210957583188
down	MATN2; NCKAP5; SORBS2; TM4SF1; XG; FAM189A2; KRT24; GGT6; KNDC1; IL22RA1; GIPC2; S100Z; P2RY13; TMEM47; GSDMC; RNF39; ADAMTS10; ETNK2; NYNRIN; FETUB;	GO:0008150~biological_process	20	603	3.3167495854063	0.00118711707751962	0.0180733813887612	1	1	0.582609722832933	0.980596180369174	0.154191469463975
down	DOC2B; DHCR24; DUOXA1; PHYHIP; WNK4; PARD3;	GO:0008104~protein localization	6	74	8.10810810810811	0.00122261698061843	0.018514843318195	1	1	0.587530530962766	0.980596180369174	0.157957763227583
down	EDN2; PTN; MDK;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.00128475439507292	0.0185767803285905	1	1	0.595469607213944	0.980596180369174	0.158486173403944
down	TRPM2; FLT3; LILRB1;	GO:0097028~dendritic cell differentiation	3	12	25	0.00128475439507292	0.0185767803285905	1	1	0.595469607213944	0.980596180369174	0.158486173403944
down	PTN; HRH2; HRH1; CX3CL1; BAIAP2;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.00132161648765239	0.0190032431330624	1	1	0.600013885394184	0.980596180369174	0.162124503447382
down	NCKAP1L; CX3CL1; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.00138292048637301	0.0196091720710342	1	1	0.60710209351775	0.980596180369174	0.167293933081326
down	TF; STEAP2; EPAS1; STEAP1;	GO:0055072~iron ion homeostasis	4	29	13.7931034482759	0.00138292048637301	0.0196091720710342	1	1	0.60710209351775	0.980596180369174	0.167293933081326
down	PLPP3; PLPP2; ALDH3B2; DEGS2; CERS3;	GO:0030148~sphingolipid biosynthetic process	5	52	9.61538461538462	0.00155267102412648	0.0218257275366414	1	1	0.621502444878033	0.980596180369174	0.186204281789117
down	MAL; SHROOM2; SHROOM3;	GO:0045176~apical protein localization	3	13	23.0769230769231	0.00156390882243584	0.0218257275366414	1	1	0.622435711329466	0.980596180369174	0.186204281789117
down	P2RY1; P2RX1; CALB2;	GO:0099509~regulation of presynaptic cytosolic calcium ion concentration	3	13	23.0769230769231	0.00156390882243584	0.0218257275366414	1	1	0.622435711329466	0.980596180369174	0.186204281789117
down	SPINT1; COBL; SDC4; GRHL2; GRHL3; SHROOM3;	GO:0001843~neural tube closure	6	78	7.69230769230769	0.00157373340304834	0.021855702431603	1	1	0.623198427607142	0.980596180369174	0.186460009978643
down	SPTA1; TAL1; FLT3; CCR2; MECOM;	GO:0030097~hemopoiesis	5	53	9.43396226415094	0.0016787152424711	0.0230884168855807	1	1	0.631181182886362	0.980596180369174	0.196976805314268
down	EDNRA; NTRK2; P2RY12; GPR55;	GO:0007202~activation of phospholipase C activity	4	31	12.9032258064516	0.00172870537650716	0.0233252332081321	1	1	0.634312129578487	0.980596180369174	0.198997183016802
down	MID1; SOSTDC1; GRHL3; SHROOM3;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.00172870537650716	0.0233252332081321	1	1	0.634312129578487	0.980596180369174	0.198997183016802
down	IGKV3-20; DEFB1; RNASE6; RNASE7;	GO:0019731~antibacterial humoral response	4	31	12.9032258064516	0.00172870537650716	0.0233252332081321	1	1	0.634312129578487	0.980596180369174	0.198997183016802
down	FGFR3; FLT3; TNFAIP8L3; P2RY12;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	4	31	12.9032258064516	0.00172870537650716	0.0233252332081321	1	1	0.634312129578487	0.980596180369174	0.198997183016802
down	KCNK1; TRPM2; SCNN1A; SCNN1B; SHROOM2; SLC4A11;	GO:0035725~sodium ion transmembrane transport	6	80	7.5	0.00177567689078151	0.0237559786161423	1	1	0.637255031424237	0.980596180369174	0.202672049717023
down	RHOD; MCF2L; TRIP10; ARHGAP40; ARHGEF16; NGEF; RHOV; ARHGAP23;	GO:0051056~regulation of small GTPase mediated signal transduction	8	141	5.67375886524823	0.00177731768361022	0.0237559786161423	1	1	0.637255031424237	0.980596180369174	0.202672049717023
down	WNT5A; GRHL3; TP63;	GO:0001736~establishment of planar polarity	3	14	21.4285714285714	0.0018782381974991	0.0243061097649089	1	1	0.643645332575009	0.980596180369174	0.207365445402181
down	SFN; EFNB2; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	3	14	21.4285714285714	0.0018782381974991	0.0243061097649089	1	1	0.643645332575009	0.980596180369174	0.207365445402181
down	TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	3	14	21.4285714285714	0.0018782381974991	0.0243061097649089	1	1	0.643645332575009	0.980596180369174	0.207365445402181
down	EDN2; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.0018782381974991	0.0243061097649089	1	1	0.643645332575009	0.980596180369174	0.207365445402181
down	LILRB2; LILRB1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.0018782381974991	0.0243061097649089	1	1	0.643645332575009	0.980596180369174	0.207365445402181
down	EPHA2; P2RY1; SOX2;	GO:0070848~response to growth factor	3	14	21.4285714285714	0.0018782381974991	0.0243061097649089	1	1	0.643645332575009	0.980596180369174	0.207365445402181
down	COBL; BMP7; PTN;	GO:1900006~positive regulation of dendrite development	3	14	21.4285714285714	0.0018782381974991	0.0243061097649089	1	1	0.643645332575009	0.980596180369174	0.207365445402181
down	TSPAN12; ERBB2; EPHA2; EMP2;	GO:0045765~regulation of angiogenesis	4	32	12.5	0.00192223925764057	0.0246514196689311	1	1	0.646234104209081	0.980596180369174	0.210311426587238
down	TFAP2A; PRRX1; IRX5; GRHL2;	GO:0048701~embryonic cranial skeleton morphogenesis	4	32	12.5	0.00192223925764057	0.0246514196689311	1	1	0.646234104209081	0.980596180369174	0.210311426587238
down	PTN; HRH2; HRH1; ADGRF1; LGMN; PAK6;	GO:0007613~memory	6	83	7.2289156626506	0.0021146593040906	0.0248559015029714	1	1	0.65631308350179	0.980596180369174	0.212055945434661
down	RHOD; AJUBA; P2RY12; ABLIM2;	GO:0030032~lamellipodium assembly	4	33	12.1212121212121	0.00213025639856868	0.0248559015029714	1	1	0.657108516128345	0.980596180369174	0.212055945434661
down	GPR55; GPR174; GPR65; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	4	33	12.1212121212121	0.00213025639856868	0.0248559015029714	1	1	0.657108516128345	0.980596180369174	0.212055945434661
down	TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	3	15	20	0.00222922519473889	0.0256947535604115	1	1	0.662079882837451	0.980596180369174	0.219212538250214
down	SOX9; FOXA1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.00222922519473889	0.0256947535604115	1	1	0.662079882837451	0.980596180369174	0.219212538250214
down	TFAP2A; PRRX1; USH1G; TIFAB; MYO6;	GO:0042472~inner ear morphogenesis	5	57	8.7719298245614	0.00225883970172569	0.0258269744209359	1	1	0.663488210459688	0.980596180369174	0.220340568934651
down	SDC1; CCND1; SLC6A1; AQP3; S100A16;	GO:0051592~response to calcium ion	5	57	8.7719298245614	0.00225883970172569	0.0258269744209359	1	1	0.663488210459688	0.980596180369174	0.220340568934651
down	LMNA; BMP7; SOX9; HHEX;	GO:0034504~protein localization to nucleus	4	34	11.7647058823529	0.00235329261093487	0.0266925261487313	1	1	0.668193800604792	0.980596180369174	0.227724947648025
down	FOXP2; EDN2; IGFBP5; FLT4;	GO:0048286~lung alveolus development	4	34	11.7647058823529	0.00235329261093487	0.0266925261487313	1	1	0.668193800604792	0.980596180369174	0.227724947648025
down	TSPAN6; CX3CL1; ECM1; CLEC6A; AJUBA; TLR9; NDFIP2; TNFRSF19; IL36A;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	9	183	4.91803278688525	0.00239286984274334	0.0270337319138503	1	1	0.670003555968135	0.980596180369174	0.230635914731695
down	CLDN4; HPGD; IGFBP2; ENDOU; IGFBP5; TEAD3;	GO:0007565~female pregnancy	6	86	6.97674418604651	0.00250030162712167	0.028135805266464	1	1	0.675081439322851	0.980596180369174	0.240038156959718
down	CD300LF; IRF6; IRF8; IRF4;	GO:0002376~immune system process	4	35	11.4285714285714	0.00259187823871831	0.0283429461929549	1	1	0.679507006818138	0.980596180369174	0.241805361621355
down	TERT; CX3CL1; UNC5B; EYA2;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	4	35	11.4285714285714	0.00259187823871831	0.0283429461929549	1	1	0.679507006818138	0.980596180369174	0.241805361621355
down	BMP7; SOX2; IRX3; NOTCH3; HES1;	GO:0045665~negative regulation of neuron differentiation	5	59	8.47457627118644	0.00259800579132752	0.0283429461929549	1	1	0.680101373788882	0.980596180369174	0.241805361621355
down	HRH2; RAB25; GRHL2;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.00261826303082091	0.0283429461929549	1	1	0.680748388013437	0.980596180369174	0.241805361621355
down	CYP2E1; CCND1; FLT3;	GO:0010243~response to organonitrogen compound	3	16	18.75	0.00261826303082091	0.0283429461929549	1	1	0.680748388013437	0.980596180369174	0.241805361621355
down	MT1X; MT1H; MT1G;	GO:0010273~detoxification of copper ion	3	16	18.75	0.00261826303082091	0.0283429461929549	1	1	0.680748388013437	0.980596180369174	0.241805361621355
down	CSTA; CSTB; ECM1;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.00261826303082091	0.0283429461929549	1	1	0.680748388013437	0.980596180369174	0.241805361621355
down	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.00261826303082091	0.0283429461929549	1	1	0.680748388013437	0.980596180369174	0.241805361621355
down	EDN2; EDNRA; BDKRB2;	GO:0042310~vasoconstriction	3	16	18.75	0.00261826303082091	0.0283429461929549	1	1	0.680748388013437	0.980596180369174	0.241805361621355
down	PTN; MDK; ANXA1;	GO:0044849~estrous cycle	3	16	18.75	0.00261826303082091	0.0283429461929549	1	1	0.680748388013437	0.980596180369174	0.241805361621355
down	GCNT3; MUC1; GALNT5; MUC20; MUC4;	GO:0016266~O-glycan processing	5	60	8.33333333333333	0.00278075362945962	0.0296986975822399	1	1	0.689049732805706	0.980596180369174	0.253371835788258
down	PTN; WNT5A; SOX2; SOX9; MARVELD3;	GO:0050680~negative regulation of epithelial cell proliferation	5	60	8.33333333333333	0.00278075362945962	0.0296986975822399	1	1	0.689049732805706	0.980596180369174	0.253371835788258
down	IGFBP2; IL1RN; SDC1; MDK; ALDH3A1;	GO:0051384~response to glucocorticoid	5	60	8.33333333333333	0.00278075362945962	0.0296986975822399	1	1	0.689049732805706	0.980596180369174	0.253371835788258
down	SHROOM2; SHROOM3; NCKAP1L; CDH3; CDH1; CDH26;	GO:0000902~cell morphogenesis	6	88	6.81818181818182	0.00278523085860838	0.0296986975822399	1	1	0.689049732805706	0.980596180369174	0.253371835788258
up	CTSV; TSPAN8; TDRKH;	GO:0007283~spermatogenesis	3	407	0.737100737100737	0.00289419428708226	0.0183317249649581	0.567262080268124	0.659876297454756	0.161485750031703	0.549054167900492	0.11015080138862
down	SCARA3; MATN2; VWA1;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	3	17	17.6470588235294	0.0030466583386648	0.0315861514695533	1	1	0.701766376447747	0.980596180369174	0.269474483221533
down	FCGR2B; P2RY1; MUC4;	GO:0010469~regulation of signaling receptor activity	3	17	17.6470588235294	0.0030466583386648	0.0315861514695533	1	1	0.701766376447747	0.980596180369174	0.269474483221533
down	CETP; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	3	17	17.6470588235294	0.0030466583386648	0.0315861514695533	1	1	0.701766376447747	0.980596180369174	0.269474483221533
down	AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	3	17	17.6470588235294	0.0030466583386648	0.0315861514695533	1	1	0.701766376447747	0.980596180369174	0.269474483221533
down	SDC4; HES1; USH1G;	GO:0060122~inner ear receptor cell stereocilium organization	3	17	17.6470588235294	0.0030466583386648	0.0315861514695533	1	1	0.701766376447747	0.980596180369174	0.269474483221533
down	MDK; WNT5A; SOX9;	GO:0061036~positive regulation of cartilage development	3	17	17.6470588235294	0.0030466583386648	0.0315861514695533	1	1	0.701766376447747	0.980596180369174	0.269474483221533
down	SOX15; KITLG; WNT5A; SOX9; RXFP2; TFAP2C;	GO:0008584~male gonad development	6	90	6.66666666666667	0.00309378680260708	0.0315861514695533	1	1	0.704261228979557	0.980596180369174	0.269474483221533
down	GJB3; DCN; ETNK2; PHLDA2;	GO:0001890~placenta development	4	37	10.8108108108108	0.00311778838587895	0.0315861514695533	1	1	0.705111534524106	0.980596180369174	0.269474483221533
down	MDK; CCR2; SOX2; HHEX; TMPRSS4;	GO:0009611~response to wounding	5	62	8.06451612903226	0.00317385247277324	0.0317051157543348	1	1	0.707769101428433	0.980596180369174	0.270489416591754
down	EPHA2; SOX9; TYRO3; P2RY12;	GO:0043491~protein kinase B signaling	4	38	10.5263157894737	0.00340614127948757	0.0337884467689935	1	1	0.719118101316226	0.980596180369174	0.288263172571355
down	DKK1; FCGR2B; WNT5A; EFNB2;	GO:1901216~positive regulation of neuron death	4	38	10.5263157894737	0.00340614127948757	0.0337884467689935	1	1	0.719118101316226	0.980596180369174	0.288263172571355
down	HPGD; AKR1C2; PTGR1;	GO:0006693~prostaglandin metabolic process	3	18	16.6666666666667	0.00351563396846621	0.0345138272697356	1	1	0.724377951293014	0.980596180369174	0.294451692744978
down	FUT3; SOX2; MAGI1;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.00351563396846621	0.0345138272697356	1	1	0.724377951293014	0.980596180369174	0.294451692744978
down	IL18; RAET1E; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	3	18	16.6666666666667	0.00351563396846621	0.0345138272697356	1	1	0.724377951293014	0.980596180369174	0.294451692744978
down	CETP; PLTP; SPNS2; GULP1; CAV2;	GO:0006869~lipid transport	5	65	7.69230769230769	0.00383632649252597	0.0375327200145066	1	1	0.740411013057511	0.980596180369174	0.320207111637418
down	DKK1; MDK; SOX9;	GO:0030279~negative regulation of ossification	3	19	15.7894736842105	0.00402633171642153	0.0386900368738283	1	1	0.749228836690589	0.980596180369174	0.330080659001676
down	EPHA2; WNT5A; TP63;	GO:0036342~post-anal tail morphogenesis	3	19	15.7894736842105	0.00402633171642153	0.0386900368738283	1	1	0.749228836690589	0.980596180369174	0.330080659001676
down	IL2RA; MDK; IL1RL2;	GO:0045582~positive regulation of T cell differentiation	3	19	15.7894736842105	0.00402633171642153	0.0386900368738283	1	1	0.749228836690589	0.980596180369174	0.330080659001676
down	RHOD; TRPM2; MDK;	GO:2000249~regulation of actin cytoskeleton reorganization	3	19	15.7894736842105	0.00402633171642153	0.0386900368738283	1	1	0.749228836690589	0.980596180369174	0.330080659001676
down	CSF3; BAIAP2L2; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	3	19	15.7894736842105	0.00402633171642153	0.0386900368738283	1	1	0.749228836690589	0.980596180369174	0.330080659001676
down	BMP7; WNT5A; SOX9; FAM83D;	GO:0001837~epithelial to mesenchymal transition	4	40	10	0.00403615769284404	0.0386900368738283	1	1	0.750661843950742	0.980596180369174	0.330080659001676
down	GLDC; SOX9; NCKAP1L; HES1; NFE4; PARD3; MAGI1;	GO:0065003~protein-containing complex assembly	7	128	5.46875	0.0040963297375648	0.0391350696739831	1	1	0.753591547682608	0.980596180369174	0.333877417335909
down	PSCA; FBLN1; NLRP6; CNKSR3; NDRG2;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	5	67	7.46268656716418	0.00432948531504462	0.0398114411276901	1	1	0.764566492521906	0.980596180369174	0.339647821119642
down	GABRP; CLDN4; CLIC3; CLCA4; ANO1; GABRE;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.00437688130416825	0.0398114411276901	1	1	0.766233103942947	0.980596180369174	0.339647821119642
down	EDN2; NMU; KCNQ1;	GO:0010460~positive regulation of heart rate	3	20	15	0.00457981498345994	0.041012217115633	1	1	0.776811265689717	0.980596180369174	0.349892136231208
down	BCAR1; NTRK2; NDN;	GO:0048011~neurotrophin TRK receptor signaling pathway	3	20	15	0.00457981498345994	0.041012217115633	1	1	0.776811265689717	0.980596180369174	0.349892136231208
down	CCL24; HRH1; CX3CL1;	GO:0048245~eosinophil chemotaxis	3	20	15	0.00457981498345994	0.041012217115633	1	1	0.776811265689717	0.980596180369174	0.349892136231208
down	CLDN7; TF; DUOX1;	GO:2000147~positive regulation of cell motility	3	20	15	0.00457981498345994	0.041012217115633	1	1	0.776811265689717	0.980596180369174	0.349892136231208
down	P4HA2; GLDC; ALDH4A1; ME1; NDUFA4L2;	GO:0022900~electron transport chain	5	68	7.35294117647059	0.00459227392001416	0.041012217115633	1	1	0.776811265689717	0.980596180369174	0.349892136231208
down	GJB6; DCN; IGFBP2; IGFBP5; GJB2; ALDH3A1; P2RY1; CX3CL1;	GO:0007568~aging	8	166	4.81927710843374	0.00459532745342006	0.041012217115633	1	1	0.776811265689717	0.980596180369174	0.349892136231208
down	CA12; CA6; HBA1; SLC4A11;	GO:0015701~bicarbonate transport	4	42	9.52380952380952	0.00474051299373146	0.0420443629070201	1	1	0.784466117779973	0.980596180369174	0.358697797598704
down	ALOX15B; HPGD; BMP7; LILRB1;	GO:0045786~negative regulation of cell cycle	4	42	9.52380952380952	0.00474051299373146	0.0420443629070201	1	1	0.784466117779973	0.980596180369174	0.358697797598704
down	FOXP2; MDK; NTRK2; GNG12; TACC2;	GO:0021987~cerebral cortex development	5	69	7.2463768115942	0.00486620235561963	0.0428918826825049	1	1	0.788850161130915	0.980596180369174	0.365928338291164
down	GJB3; LTK; WNT5A; SOX9; PTK6;	GO:0071300~cellular response to retinoic acid	5	69	7.2463768115942	0.00486620235561963	0.0428918826825049	1	1	0.788850161130915	0.980596180369174	0.365928338291164
up	S100A6; S100A11; SNX27; PI4KB;	GO:0007165~signal transduction	4	989	0.404448938321537	0.00487679744260472	0.0199991274564114	0.870650829869442	1	0.210896664966872	0.549054167900492	0.120169810566536
down	MAL; NHLH2; GRHL3; NDN; NPAS2; SH3GL3; SOX9;	GO:0007417~central nervous system development	7	133	5.26315789473684	0.00499122057517221	0.0438580400540595	1	1	0.79280981057329	0.980596180369174	0.374171025237729
down	CLDN7; CYP2E1; CSF3; HPGD; CCND1; ADH7;	GO:0045471~response to ethanol	6	100	6	0.00503248500888887	0.0440845686778665	1	1	0.79383750584841	0.980596180369174	0.376103634339985
down	ERBB2; SOX9; GAREM1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	4	43	9.30232558139535	0.00512175648441837	0.044728959236623	1	1	0.795940696178889	0.980596180369174	0.381601195921083
down	FMO2; CYP2J2; CYP2E1;	GO:0006082~organic acid metabolic process	3	21	14.2857142857143	0.00517707136580314	0.0447456852166068	1	1	0.797268990333684	0.980596180369174	0.381743892153539
down	SCEL; CAMSAP3; STOX2;	GO:0009792~embryo development ending in birth or egg hatching	3	21	14.2857142857143	0.00517707136580314	0.0447456852166068	1	1	0.797268990333684	0.980596180369174	0.381743892153539
down	FCGR2B; TREML2; TREML4;	GO:0045088~regulation of innate immune response	3	21	14.2857142857143	0.00517707136580314	0.0447456852166068	1	1	0.797268990333684	0.980596180369174	0.381743892153539
down	TF; SFN; BTC; WNT5A; DHCR24; TRIP10; BAIAP2L2;	GO:0061024~membrane organization	7	134	5.22388059701492	0.00518653885545495	0.0447456852166068	1	1	0.7981101287245	0.980596180369174	0.381743892153539
up	S100A8; S100A12; NLRP10;	GO:0045087~innate immune response	3	505	0.594059405940594	0.00526068550251346	0.0199991274564114	0.910098591934829	1	0.218054278136588	0.549054167900492	0.120169810566536
down	IGKV3D-20; IGKV1-12; IGKV1-17; IGKV3-20; IGLV1-44; IGHV4-59; IGKV1-16; IGKV2-30;	GO:0038095~Fc-epsilon receptor signaling pathway	8	171	4.67836257309941	0.00543449019529973	0.045638391766174	1	1	0.804304548904361	0.980596180369174	0.389359939849156
down	EPHB3; NTRK2; PROM2; NGEF; AJUBA;	GO:0043087~regulation of GTPase activity	5	71	7.04225352112676	0.00544847179649621	0.045638391766174	1	1	0.80504872703154	0.980596180369174	0.389359939849156
down	CD40LG; GP5; P2RY1; P2RX1; TYRO3; PIK3R5;	GO:0030168~platelet activation	6	102	5.88235294117647	0.00550779461654261	0.045638391766174	1	1	0.806272618677365	0.980596180369174	0.389359939849156
down	SULT2B1; CYP2E1; AKR1C2; DHCR24;	GO:0008202~steroid metabolic process	4	44	9.09090909090909	0.00552299259636557	0.045638391766174	1	1	0.806356919069374	0.980596180369174	0.389359939849156
down	IRF6; MID1; IRF8; IRF4; FCGR1B;	GO:0060333~interferon-gamma-mediated signaling pathway	5	72	6.94444444444444	0.00575730545793274	0.045638391766174	1	1	0.812711352988009	0.980596180369174	0.389359939849156
down	ERBB2; FGFR3; FLT4; FLT3; EPHB3; TYRO3; PTK6; NTRK2;	GO:0046777~protein autophosphorylation	8	173	4.6242774566474	0.00580103490397976	0.045638391766174	1	1	0.814066876000776	0.980596180369174	0.389359939849156
down	BMP7; FGFR3; EPHA2; SOX9; PITX1; TEAD4; TP63;	GO:0001501~skeletal system development	7	137	5.10948905109489	0.00580697516199846	0.045638391766174	1	1	0.814066876000776	0.980596180369174	0.389359939849156
down	TRPM2; EDN2; NMU;	GO:0001659~temperature homeostasis	3	22	13.6363636363636	0.0058190151777735	0.045638391766174	1	1	0.81466212488829	0.980596180369174	0.389359939849156
down	NCR1; IL18; ULBP2;	GO:0030101~natural killer cell activation	3	22	13.6363636363636	0.0058190151777735	0.045638391766174	1	1	0.81466212488829	0.980596180369174	0.389359939849156
down	PTN; MDK; SOX2;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.0058190151777735	0.045638391766174	1	1	0.81466212488829	0.980596180369174	0.389359939849156
down	KRT3; PPL; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	3	22	13.6363636363636	0.0058190151777735	0.045638391766174	1	1	0.81466212488829	0.980596180369174	0.389359939849156
down	ORM2; WNT5A; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	3	22	13.6363636363636	0.0058190151777735	0.045638391766174	1	1	0.81466212488829	0.980596180369174	0.389359939849156
down	LGMN; TLR9; TLR8; TLR7;	GO:0002224~toll-like receptor signaling pathway	4	45	8.88888888888889	0.00594467067609505	0.0463684312735414	1	1	0.818279988067485	0.980596180369174	0.395588207929513
down	CLDN7; MDK; ERBB3; FBLN1;	GO:0007162~negative regulation of cell adhesion	4	45	8.88888888888889	0.00594467067609505	0.0463684312735414	1	1	0.818279988067485	0.980596180369174	0.395588207929513
down	GJB6; DCN; HPGD; GJB2; BDKRB1; S100A14; GNG12;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.00602561629607123	0.0468713923358328	1	1	0.819735426781439	0.980596180369174	0.399879176155641
down	DKK1; SSTR3; SOX2; NOTCH3;	GO:0030900~forebrain development	4	46	8.69565217391304	0.00638722996119834	0.049397271394291	1	1	0.830339894955784	0.980596180369174	0.421428491988379
down	WNT5A; CCR2; IRF8; IL18;	GO:0032729~positive regulation of interferon-gamma production	4	46	8.69565217391304	0.00638722996119834	0.049397271394291	1	1	0.830339894955784	0.980596180369174	0.421428491988379
down	TRPM2; CCR5; BSPRY; CACNG6; TRPV5;	GO:0006816~calcium ion transport	5	74	6.75675675675676	0.00641158910165873	0.049397271394291	1	1	0.830714804264374	0.980596180369174	0.421428491988379
down	TSPAN12; TFAP2A; FJX1;	GO:0010842~retina layer formation	3	23	13.0434782608696	0.00650648990968006	0.049397271394291	1	1	0.832830708439047	0.980596180369174	0.421428491988379
down	KANK1; EPS8L1; EPS8L2;	GO:0035023~regulation of Rho protein signal transduction	3	23	13.0434782608696	0.00650648990968006	0.049397271394291	1	1	0.832830708439047	0.980596180369174	0.421428491988379
down	PRRX1; HES1; NOTCH3;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.00650648990968006	0.049397271394291	1	1	0.832830708439047	0.980596180369174	0.421428491988379
down	RHOD; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	3	23	13.0434782608696	0.00650648990968006	0.049397271394291	1	1	0.832830708439047	0.980596180369174	0.421428491988379
down	ANXA1; SSTR3; FLT3;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.00650648990968006	0.049397271394291	1	1	0.832830708439047	0.980596180369174	0.421428491988379
down	SOX2; PRRX1; HES1;	GO:0097150~neuronal stem cell population maintenance	3	23	13.0434782608696	0.00650648990968006	0.049397271394291	1	1	0.832830708439047	0.980596180369174	0.421428491988379
down	DEFB1; IRF8; GBP6; S100A14; TLR9; STAB1; GSDMC; IGHV4-61; IGHV4-59;	GO:0042742~defense response to bacterium	9	216	4.16666666666667	0.00671066623342631	0.0508118796983104	1	1	0.838833279178289	0.980596180369174	0.433497098765434
down	DKK1; WNT5A; NBL1; SOSTDC1;	GO:0030514~negative regulation of BMP signaling pathway	4	47	8.51063829787234	0.00685109931452499	0.0517376120648611	1	1	0.842685215686574	0.980596180369174	0.44139490332444
down	DKK1; IGFBP2; MDK; WNT5A; SOX2; SOX9; SOSTDC1; WWTR1;	GO:0090090~negative regulation of canonical Wnt signaling pathway	8	179	4.46927374301676	0.00701402680610408	0.0522593422712673	1	1	0.844857084027853	0.980596180369174	0.445845998858757
down	IRF8; IRF4; GBP6;	GO:0042832~defense response to protozoan	3	24	12.5	0.00724027062153465	0.0522593422712673	1	1	0.847228427784676	0.980596180369174	0.445845998858757
down	BDKRB2; PLA2G4F; ANXA1;	GO:0050482~arachidonic acid secretion	3	24	12.5	0.00724027062153465	0.0522593422712673	1	1	0.847228427784676	0.980596180369174	0.445845998858757
down	FOXP2; PTN; FCGR2B; SSTR3;	GO:0021549~cerebellum development	4	48	8.33333333333333	0.00733669698110861	0.0522593422712673	1	1	0.848885328230148	0.980596180369174	0.445845998858757
down	GRHL3; BAIAP2; ARHGAP40; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	5	77	6.49350649350649	0.00748815019995908	0.0530317502967251	1	1	0.850607205163677	0.980596180369174	0.452435730238252
down	GPX3; HBA1; NXN; LOXHD1; DUOX1;	GO:0098869~cellular oxidant detoxification	5	77	6.49350649350649	0.00748815019995908	0.0530317502967251	1	1	0.850607205163677	0.980596180369174	0.452435730238252
down	PRLR; SOX9; FUT2; IL18;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.007844430366442	0.0554171048467999	1	1	0.855042909942178	0.980596180369174	0.472786173542532
down	PYCR1; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	3	25	12	0.00802106627445465	0.0559705286357166	1	1	0.857204712572149	0.980596180369174	0.477507660098581
down	CD40LG; IL20RB; TLR9;	GO:0032733~positive regulation of interleukin-10 production	3	25	12	0.00802106627445465	0.0559705286357166	1	1	0.857204712572149	0.980596180369174	0.477507660098581
down	DKK1; BDKRB2; CNKSR3;	GO:0033137~negative regulation of peptidyl-serine phosphorylation	3	25	12	0.00802106627445465	0.0559705286357166	1	1	0.857204712572149	0.980596180369174	0.477507660098581
down	CYP4B1; CYP2J2; CYP2E1;	GO:0042738~exogenous drug catabolic process	3	25	12	0.00802106627445465	0.0559705286357166	1	1	0.857204712572149	0.980596180369174	0.477507660098581
down	MT1G; MT1H; MT1X;	GO:0071294~cellular response to zinc ion	3	25	12	0.00802106627445465	0.0559705286357166	1	1	0.857204712572149	0.980596180369174	0.477507660098581
down	EYA2; TFAP2C; SPARCL1; TFAP2A;	GO:0048856~anatomical structure development	4	50	8	0.00837469583515627	0.0582952543831049	1	1	0.861430431603007	0.980596180369174	0.497340854085923
down	PTN; WNT5A; SIM2; HES1; EPAS1;	GO:0030324~lung development	5	80	6.25	0.00868450089021056	0.0590749153000245	1	1	0.864851823431969	0.980596180369174	0.503992462873321
down	DEFB1; IL22RA1; RNASE6; RNASE7; TLR9;	GO:0050829~defense response to Gram-negative bacterium	5	80	6.25	0.00868450089021056	0.0590749153000245	1	1	0.864851823431969	0.980596180369174	0.503992462873321
down	GJB3; GJB5; TRIP10;	GO:0007154~cell communication	3	26	11.5384615384615	0.00884952200017575	0.0590749153000245	1	1	0.867253156017223	0.980596180369174	0.503992462873321
down	CETP; PLTP; TNFAIP8L3;	GO:0015914~phospholipid transport	3	26	11.5384615384615	0.00884952200017575	0.0590749153000245	1	1	0.867253156017223	0.980596180369174	0.503992462873321
down	CD40LG; IRF8; TLR9;	GO:0032735~positive regulation of interleukin-12 production	3	26	11.5384615384615	0.00884952200017575	0.0590749153000245	1	1	0.867253156017223	0.980596180369174	0.503992462873321
down	KIF20A; PLK1; ESPL1; RTKN;	GO:0000281~mitotic cytokinesis	4	51	7.84313725490196	0.0089278785290845	0.0590749153000245	1	1	0.867265363404337	0.980596180369174	0.503992462873321
down	NBL1; FOXA1; IRX3; DUOXA1; SH3GL3;	GO:0045666~positive regulation of neuron differentiation	5	81	6.17283950617284	0.00911097150764284	0.0590864143103853	1	1	0.86979383385158	0.980596180369174	0.504090565672503
down	PRSS3; DEFB1; RNASE6; RNASE7;	GO:0019730~antimicrobial humoral response	4	52	7.69230769230769	0.00950435220427615	0.0613580288561773	1	1	0.874400402793405	0.980596180369174	0.523470646097808
down	ZBTB7C; KLF5; CDS1; CCDC3;	GO:0045600~positive regulation of fat cell differentiation	4	52	7.69230769230769	0.00950435220427615	0.0613580288561773	1	1	0.874400402793405	0.980596180369174	0.523470646097808
down	TRPM2; RASAL1; WNT5A; LGMN; SYT8;	GO:0071277~cellular response to calcium ion	5	82	6.09756097560976	0.00955165741115049	0.0613981199003106	1	1	0.875230045313152	0.980596180369174	0.523812679327467
down	ERBB2; PTN; ERBB3; EDNRA; CXADR; RBM20; PDLIM4; SOX9;	GO:0007507~heart development	8	190	4.21052631578947	0.00972258781418722	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	CX3CL1; TLR8; TLR7;	GO:0001774~microglial cell activation	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	JUP; EMP2; CX3CL1;	GO:0001954~positive regulation of cell-matrix adhesion	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	NFASC; ERBB2; ERBB3;	GO:0007422~peripheral nervous system development	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	ALOX15B; MGLL; CYP4F11;	GO:0019369~arachidonic acid metabolic process	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	SOX9; DEFB1; PCLO;	GO:0019933~cAMP-mediated signaling	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	CDH1; SOX2; PITX1;	GO:0021983~pituitary gland development	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	MECOM; SH3RF2; MARVELD3;	GO:0046329~negative regulation of JNK cascade	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	CETP; IL18; ANGPTL4;	GO:0070328~triglyceride homeostasis	3	27	11.1111111111111	0.00972622131192136	0.0613981199003106	1	1	0.876675114182684	0.980596180369174	0.523812679327467
down	SLC15A1; SLC9A3; OTOP2; SLC4A11; ATP6V1C2; NDUFA4L2;	GO:1902600~proton transmembrane transport	6	116	5.17241379310345	0.00979746810763837	0.0617110435894833	1	1	0.878157236100153	0.980596180369174	0.526482360358689
down	CETP; CD24; IL18; LIPG; CYP7B1;	GO:0042632~cholesterol homeostasis	5	83	6.02409638554217	0.0100067771369357	0.0628902748539863	1	1	0.880596388050337	0.980596180369174	0.536542868550291
down	CD24; CD40LG; EFNB2; ICOS;	GO:0031295~T cell costimulation	4	53	7.54716981132075	0.0101044790858704	0.0632251691373035	1	1	0.881238489560153	0.980596180369174	0.539399989780073
down	NFASC; ERBB2; MAL; MAL2;	GO:0042552~myelination	4	53	7.54716981132075	0.0101044790858704	0.0632251691373035	1	1	0.881238489560153	0.980596180369174	0.539399989780073
down	ATP13A5; ATP13A4; ANO1;	GO:0006812~cation transport	3	28	10.7142857142857	0.0106516882563207	0.0659299035992858	1	1	0.887148408815968	0.980596180369174	0.562475194814049
down	FLT4; CXCL17; SULF1;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.0106516882563207	0.0659299035992858	1	1	0.887148408815968	0.980596180369174	0.562475194814049
down	GPX3; HBA1; DUOX1;	GO:0042744~hydrogen peroxide catabolic process	3	28	10.7142857142857	0.0106516882563207	0.0659299035992858	1	1	0.887148408815968	0.980596180369174	0.562475194814049
down	NCKAP1L; SPNS2; GPR174;	GO:0043029~T cell homeostasis	3	28	10.7142857142857	0.0106516882563207	0.0659299035992858	1	1	0.887148408815968	0.980596180369174	0.562475194814049
down	EDN2; CCR5; P2RY12; CCR2; CXCR1;	GO:0019722~calcium-mediated signaling	5	85	5.88235294117647	0.0109611762717781	0.0659299035992858	1	1	0.890082100644063	0.980596180369174	0.562475194814049
down	ERBB2; NTRK2; SOX9;	GO:0048709~oligodendrocyte differentiation	3	29	10.3448275862069	0.0116263895082742	0.0691029873278845	1	1	0.896467194622858	0.980596180369174	0.589546080572543
down	ERBB2; EPHA2; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	3	29	10.3448275862069	0.0116263895082742	0.0691029873278845	1	1	0.896467194622858	0.980596180369174	0.589546080572543
down	MT1G; MT1X; MT1H;	GO:0071280~cellular response to copper ion	3	29	10.3448275862069	0.0116263895082742	0.0691029873278845	1	1	0.896467194622858	0.980596180369174	0.589546080572543
down	ERBB2; ERBB3; BTC;	GO:2000145~regulation of cell motility	3	29	10.3448275862069	0.0116263895082742	0.0691029873278845	1	1	0.896467194622858	0.980596180369174	0.589546080572543
down	CAV2; BCAR1; ATP6V1C2; BAIAP2; GRB7;	GO:0008286~insulin receptor signaling pathway	5	88	5.68181818181818	0.0125063047056767	0.074178019785545	1	1	0.905588757449709	0.980596180369174	0.632843275236439
down	MT1X; MT1H; MT1G;	GO:0006882~cellular zinc ion homeostasis	3	30	10	0.0126507364104729	0.0742611269291057	1	1	0.907589616392372	0.980596180369174	0.633552296548663
down	PIR; PRSS3; AKR1C2;	GO:0007586~digestion	3	30	10	0.0126507364104729	0.0742611269291057	1	1	0.907589616392372	0.980596180369174	0.633552296548663
down	BMP7; WNT5A; PLK1;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	3	30	10	0.0126507364104729	0.0742611269291057	1	1	0.907589616392372	0.980596180369174	0.633552296548663
down	LGI3; PCLO; RAB3B;	GO:0017157~regulation of exocytosis	3	30	10	0.0126507364104729	0.0742611269291057	1	1	0.907589616392372	0.980596180369174	0.633552296548663
down	IGFBP5; NDRG4; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	3	30	10	0.0126507364104729	0.0742611269291057	1	1	0.907589616392372	0.980596180369174	0.633552296548663
down	PLPP3; PLPP2; TNFAIP8L3; PLA2G4F;	GO:0006644~phospholipid metabolic process	4	57	7.01754385964912	0.012748352927437	0.0745268188591648	1	1	0.907589616392372	0.980596180369174	0.635819023966146
down	CYP7B1; ERBB2; SOX9; ESRP2;	GO:0050679~positive regulation of epithelial cell proliferation	4	57	7.01754385964912	0.012748352927437	0.0745268188591648	1	1	0.907589616392372	0.980596180369174	0.635819023966146
down	FLT3; SOX9; BCAR1; TNFAIP8L3; PERP; RTKN; TP63; TP53AIP1;	GO:0042981~regulation of apoptotic process	8	202	3.96039603960396	0.0134901510051456	0.0769668535303598	1	1	0.916283003522568	0.980596180369174	0.656635965931891
down	GHR; PRLR; CCR2;	GO:0007259~receptor signaling pathway via JAK-STAT	3	31	9.67741935483871	0.013725086958301	0.0775304019251645	1	1	0.918646994759726	0.980596180369174	0.661443829675807
down	PTK6; FRK; SLA;	GO:0038083~peptidyl-tyrosine autophosphorylation	3	31	9.67741935483871	0.013725086958301	0.0775304019251645	1	1	0.918646994759726	0.980596180369174	0.661443829675807
down	TAL1; FOXA1; LGMN;	GO:0045931~positive regulation of mitotic cell cycle	3	31	9.67741935483871	0.013725086958301	0.0775304019251645	1	1	0.918646994759726	0.980596180369174	0.661443829675807
down	P2RX1; CERS3; DEGS2;	GO:0046513~ceramide biosynthetic process	3	31	9.67741935483871	0.013725086958301	0.0775304019251645	1	1	0.918646994759726	0.980596180369174	0.661443829675807
down	WNT5A; KIAA1217; SULF1;	GO:0048706~embryonic skeletal system development	3	31	9.67741935483871	0.013725086958301	0.0775304019251645	1	1	0.918646994759726	0.980596180369174	0.661443829675807
down	EDNRA; P2RY1; RXFP2; P2RY12;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	4	59	6.77966101694915	0.0142207607377316	0.0798550410657236	1	1	0.923632867187187	0.980596180369174	0.681276284784576
down	WNT5A; DUOXA1; AJUBA; FRMD6;	GO:0034613~cellular protein localization	4	59	6.77966101694915	0.0142207607377316	0.0798550410657236	1	1	0.923632867187187	0.980596180369174	0.681276284784576
down	TRPM2; TK1; TRPV5; UPB1;	GO:0051289~protein homotetramerization	4	59	6.77966101694915	0.0142207607377316	0.0798550410657236	1	1	0.923632867187187	0.980596180369174	0.681276284784576
down	ME1; TNFAIP8L3; NPAS2; ANGPTL4; GRHL1;	GO:0019216~regulation of lipid metabolic process	5	92	5.43478260869565	0.0147867910369825	0.08257271834346	1	1	0.928995031873325	0.980596180369174	0.704461910316919
down	KIF20A; PLK1; NCKAP5;	GO:0001578~microtubule bundle formation	3	32	9.375	0.0148497477315952	0.08257271834346	1	1	0.928995031873325	0.980596180369174	0.704461910316919
down	TLR9; TLR8; TLR7;	GO:0002755~MyD88-dependent toll-like receptor signaling pathway	3	32	9.375	0.0148497477315952	0.08257271834346	1	1	0.928995031873325	0.980596180369174	0.704461910316919
down	SLC6A1; SLC6A11; TMEM184A;	GO:0006810~transport	3	32	9.375	0.0148497477315952	0.08257271834346	1	1	0.928995031873325	0.980596180369174	0.704461910316919
down	TERT; ANXA1; CCND1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	3	32	9.375	0.0148497477315952	0.08257271834346	1	1	0.928995031873325	0.980596180369174	0.704461910316919
down	HRH1; P2RY1; ANO1; P2RY12;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	4	60	6.66666666666667	0.0149956110673373	0.0832212567421232	1	1	0.929727886174911	0.980596180369174	0.709994858830686
down	UNC13B; SNCG; SLC6A1; GABRP; HRH2; GABRE; DLG2; HRH1; CHRNG;	GO:0007268~chemical synaptic transmission	9	249	3.6144578313253	0.0154057481501509	0.0843464711220764	1	1	0.93477775849563	0.980596180369174	0.719594526705502
down	OVOL1; TFAP2A; DCN; HPGD; SULF1;	GO:0001822~kidney development	5	94	5.31914893617021	0.0160248662482374	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	GSTA4; CYP2E1; ALDH3A1; CYP2J2; FMO2;	GO:0006805~xenobiotic metabolic process	5	94	5.31914893617021	0.0160248662482374	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	IL1RN; PCLO; ANXA1;	GO:0030073~insulin secretion	3	33	9.09090909090909	0.0160249757747273	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	TFAP2A; CRABP2; TP63;	GO:0035115~embryonic forelimb morphogenesis	3	33	9.09090909090909	0.0160249757747273	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	SDC1; PAX9; AQP3;	GO:0042476~odontogenesis	3	33	9.09090909090909	0.0160249757747273	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	CCL26; CX3CL1; CCL24;	GO:0048247~lymphocyte chemotaxis	3	33	9.09090909090909	0.0160249757747273	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	SPINT1; BMP7; SOX9;	GO:0071773~cellular response to BMP stimulus	3	33	9.09090909090909	0.0160249757747273	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	EYA2; KITLG; ERBB3;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	3	33	9.09090909090909	0.0160249757747273	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	TERT; HPGD; IGFBP5;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	3	33	9.09090909090909	0.0160249757747273	0.0862440567687118	1	1	0.941032544434042	0.980596180369174	0.73578361235554
down	PTN; SLC6A1; NTRK2; PAK6;	GO:0007612~learning	4	62	6.45161290322581	0.0166239380818309	0.0889630671409261	1	1	0.947564470664363	0.980596180369174	0.758980611066595
down	KRT19; IGFBP2; CCND1; CD24;	GO:0043627~response to estrogen	4	62	6.45161290322581	0.0166239380818309	0.0889630671409261	1	1	0.947564470664363	0.980596180369174	0.758980611066595
down	SRPX2; EPHB3; TPBG; NTRK2;	GO:0051965~positive regulation of synapse assembly	4	62	6.45161290322581	0.0166239380818309	0.0889630671409261	1	1	0.947564470664363	0.980596180369174	0.758980611066595
down	EPHA2; DEFB1; RNASE6; RNASE7; GBP6;	GO:0050830~defense response to Gram-positive bacterium	5	95	5.26315789473684	0.0166689907416999	0.0890368042056654	1	1	0.947819652579978	0.980596180369174	0.759609692372498
down	F13A1; ANXA8; GP5; P2RX1; DOCK6; CYP4F11; EHD3;	GO:0007596~blood coagulation	7	171	4.09356725146199	0.0172500628877641	0.0903395504482887	1	1	0.951434525396835	0.980596180369174	0.770723957775742
down	ERBB2; PDZRN3; UNC13B;	GO:0007528~neuromuscular junction development	3	34	8.82352941176471	0.0172509804254219	0.0903395504482887	1	1	0.951434525396835	0.980596180369174	0.770723957775742
down	PRODH; DKK1; HBA1;	GO:0010942~positive regulation of cell death	3	34	8.82352941176471	0.0172509804254219	0.0903395504482887	1	1	0.951434525396835	0.980596180369174	0.770723957775742
down	OVOL1; GJB3; DHCR24;	GO:0043588~skin development	3	34	8.82352941176471	0.0172509804254219	0.0903395504482887	1	1	0.951434525396835	0.980596180369174	0.770723957775742
down	SLC15A1; SLC9A3; P2RX1; WNK4; STEAP1;	GO:0006811~ion transport	5	96	5.20833333333333	0.0173300685011201	0.0903395504482887	1	1	0.953153767561604	0.980596180369174	0.770723957775742
down	ITGB5; EMP2; MUC4; PARVG; LYPD3;	GO:0007160~cell-matrix adhesion	5	96	5.20833333333333	0.0173300685011201	0.0903395504482887	1	1	0.953153767561604	0.980596180369174	0.770723957775742
down	SPI1; SOX2; SOX9; HES1;	GO:0035019~somatic stem cell population maintenance	4	63	6.34920634920635	0.0174779117712867	0.0903395504482887	1	1	0.955210059227775	0.980596180369174	0.770723957775742
down	PRLR; CCR2; IL18; IRF4; EPAS1;	GO:0120162~positive regulation of cold-induced thermogenesis	5	97	5.15463917525773	0.0180082657844804	0.0918808829541503	1	1	0.959157208232848	0.980596180369174	0.783873700975384
down	TGM1; CCND1; PTK6;	GO:0045787~positive regulation of cell cycle	3	35	8.57142857142857	0.0185279250953403	0.0940267428635184	1	1	0.963452104957695	0.980596180369174	0.802180916740501
down	EDN2; NMU; IRX3;	GO:0097009~energy homeostasis	3	35	8.57142857142857	0.0185279250953403	0.0940267428635184	1	1	0.963452104957695	0.980596180369174	0.802180916740501
down	TERT; SPI1; KLF5;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	3	35	8.57142857142857	0.0185279250953403	0.0940267428635184	1	1	0.963452104957695	0.980596180369174	0.802180916740501
down	ANXA1; SSTR3; HRH1; HRH2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	4	65	6.15384615384615	0.0192666310910475	0.0976015991391679	1	1	0.966085732004488	0.980596180369174	0.832679489774967
down	EML1; AK4; SLC6A11; SHROOM2; CTTNBP2; BAIAP2; NDRG4; GRHL2;	GO:0007420~brain development	8	217	3.68663594470046	0.0195754058246123	0.0988222124348982	1	1	0.966472320932861	0.980596180369174	0.843093045139486
down	BTC; SOX2; PPP1R13L;	GO:0045597~positive regulation of cell differentiation	3	36	8.33333333333333	0.0198559290001181	0.0988222124348982	1	1	0.96687501773325	0.980596180369174	0.843093045139486
down	IRF6; TFAP2A; EPHB3; PRRX1;	GO:0060021~roof of mouth development	4	66	6.06060606060606	0.0202018010667758	0.0988222124348982	1	1	0.967294850567698	0.980596180369174	0.843093045139486
down	TIFAB; TLR8; TLR7; TLR9;	GO:0007249~I-kappaB kinase/NF-kappaB signaling	4	67	5.97014925373134	0.0211644407389348	0.0998258989113106	1	1	0.968190493947853	0.980596180369174	0.851655908355297
down	FOXP2; PPP1R13L; NDN; ETNK2;	GO:0009791~post-embryonic development	4	67	5.97014925373134	0.0211644407389348	0.0998258989113106	1	1	0.968190493947853	0.980596180369174	0.851655908355297
down	BMP7; SDC1; SDC4;	GO:0001657~ureteric bud development	3	37	8.10810810810811	0.0212350688442358	0.0998258989113106	1	1	0.968190493947853	0.980596180369174	0.851655908355297
down	CLIC3; ANO1; WNK4;	GO:0006821~chloride transport	3	37	8.10810810810811	0.0212350688442358	0.0998258989113106	1	1	0.968190493947853	0.980596180369174	0.851655908355297
down	TACSTD2; SCNN1A; SCNN1B; IRX5;	GO:0050896~response to stimulus	4	68	5.88235294117647	0.0221547322344502	0.0998258989113106	1	1	0.969169452991278	0.980596180369174	0.851655908355297
down	ADGRF1; GPR65; ADGRE1; ADGRE3; RXFP2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	5	103	4.85436893203883	0.0224457261654746	0.0998258989113106	1	1	0.969169452991278	0.980596180369174	0.851655908355297
down	TF; CD40LG; WNT5A;	GO:0007257~activation of JUN kinase activity	3	38	7.89473684210526	0.0226653804593064	0.0998258989113106	1	1	0.969693895335971	0.980596180369174	0.851655908355297
down	ESRP1; ESRP2; RBM20;	GO:0043484~regulation of RNA splicing	3	38	7.89473684210526	0.0226653804593064	0.0998258989113106	1	1	0.969693895335971	0.980596180369174	0.851655908355297
down	ANXA8; LAPTM4B; ANXA8L1;	GO:0007032~endosome organization	3	39	7.69230769230769	0.0241468603963155	0.0998258989113106	1	1	0.970821446377059	0.980596180369174	0.851655908355297
down	DKK1; BMP7; PRRX1;	GO:0030326~embryonic limb morphogenesis	3	39	7.69230769230769	0.0241468603963155	0.0998258989113106	1	1	0.970821446377059	0.980596180369174	0.851655908355297
down	TFAP2A; BMP7; PTN;	GO:0030501~positive regulation of bone mineralization	3	39	7.69230769230769	0.0241468603963155	0.0998258989113106	1	1	0.970821446377059	0.980596180369174	0.851655908355297
down	TAL1; ERBB3; CD24;	GO:0061098~positive regulation of protein tyrosine kinase activity	3	39	7.69230769230769	0.0241468603963155	0.0998258989113106	1	1	0.970821446377059	0.980596180369174	0.851655908355297
down	MT1G; MT1H; MT1X;	GO:0071276~cellular response to cadmium ion	3	39	7.69230769230769	0.0241468603963155	0.0998258989113106	1	1	0.970821446377059	0.980596180369174	0.851655908355297
down	TERT; SPTA1; CSF3; WNT5A;	GO:0032092~positive regulation of protein binding	4	70	5.71428571428571	0.0242189396688193	0.0998258989113106	1	1	0.970821446377059	0.980596180369174	0.851655908355297
down	SCEL; JUP; CDH3; KANK1; NRARP; ZBED2;	GO:0090263~positive regulation of canonical Wnt signaling pathway	6	144	4.16666666666667	0.0246372669220446	0.0998258989113106	1	1	0.971428589245337	0.980596180369174	0.851655908355297
down	PLPP3; FBLN1; BDKRB1; WWTR1;	GO:0001933~negative regulation of protein phosphorylation	4	71	5.63380281690141	0.0252931605367269	0.0998258989113106	1	1	0.97206768700142	0.980596180369174	0.851655908355297
down	TF; HSPB1; CDH3;	GO:0001895~retina homeostasis	3	40	7.5	0.0256794674744286	0.0998258989113106	1	1	0.972741330582155	0.980596180369174	0.851655908355297
down	PRLR; FBLN1; EMP2;	GO:0007566~embryo implantation	3	40	7.5	0.0256794674744286	0.0998258989113106	1	1	0.972741330582155	0.980596180369174	0.851655908355297
down	RAB25; RAB3B; RAB39A; RAB7B;	GO:0032482~Rab protein signal transduction	4	72	5.55555555555556	0.0263956432444411	0.0998258989113106	1	1	0.973452398806265	0.980596180369174	0.851655908355297
down	CRYAB; SFN; NAIP; DHCR24;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	4	72	5.55555555555556	0.0263956432444411	0.0998258989113106	1	1	0.973452398806265	0.980596180369174	0.851655908355297
down	NCKAP1L; FCRL3; TLR9;	GO:0030890~positive regulation of B cell proliferation	3	41	7.31707317073171	0.027263124287626	0.0998258989113106	1	1	0.974204099500324	0.980596180369174	0.851655908355297
down	SULT2B1; CYP7B1; CYP11A1; CETP;	GO:0008203~cholesterol metabolic process	4	73	5.47945205479452	0.0275265110683105	0.0998258989113106	1	1	0.974204099500324	0.980596180369174	0.851655908355297
down	SPINT1; CSTA; CSTB; CST6; FETUB; SERPINB13;	GO:0010951~negative regulation of endopeptidase activity	6	148	4.05405405405405	0.0275603608156756	0.0998258989113106	1	1	0.974204099500324	0.980596180369174	0.851655908355297
down	ME1; DHCR24; STEAP2;	GO:0009725~response to hormone	3	42	7.14285714285714	0.0288977186686159	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	BMP7; MDK; WWTR1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	3	42	7.14285714285714	0.0288977186686159	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	CLDN4; PTN; GJB2;	GO:0032570~response to progesterone	3	42	7.14285714285714	0.0288977186686159	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	FOXP2; SHROOM2; GRHL2;	GO:0043010~camera-type eye development	3	42	7.14285714285714	0.0288977186686159	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	TRIM16; SPI1; IRF4;	GO:0043966~histone H3 acetylation	3	42	7.14285714285714	0.0288977186686159	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	BMP7; NRARP; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	3	42	7.14285714285714	0.0288977186686159	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	DKK1; ADH7; CLEC12B;	GO:2000272~negative regulation of signaling receptor activity	3	42	7.14285714285714	0.0288977186686159	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	PLPP3; CSF3; JUP; FOXA1; NHLH2;	GO:0051091~positive regulation of DNA-binding transcription factor activity	5	111	4.5045045045045	0.0293832466763886	0.0998258989113106	1	1	0.975844173741907	0.980596180369174	0.851655908355297
down	COBL; PTN; AK4; HES1;	GO:0001889~liver development	4	75	5.33333333333333	0.0298738377325369	0.101250971457777	1	1	0.976741089342773	0.980596180369174	0.863813789899758
down	CLDN4; NTRK2; ARNTL2; NPAS2;	GO:0007623~circadian rhythm	4	75	5.33333333333333	0.0298738377325369	0.101250971457777	1	1	0.976741089342773	0.980596180369174	0.863813789899758
down	MUC1; ICAM3; CLEC6A; MUC20; MUC4;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	5	112	4.46428571428571	0.0303351826433096	0.10269234837753	1	1	0.976741089342773	0.980596180369174	0.876110770776082
down	RHOD; RASSF9; AP1M2;	GO:0006605~protein targeting	3	43	6.97674418604651	0.0305831051109218	0.103286002669981	1	1	0.977695870466275	0.980596180369174	0.881175480347455
down	HSPB1; TYRO3; P2RY12;	GO:0070527~platelet aggregation	3	43	6.97674418604651	0.0305831051109218	0.103286002669981	1	1	0.977695870466275	0.980596180369174	0.881175480347455
down	MGP; BMP7; SOX9; ECM1;	GO:0001503~ossification	4	76	5.26315789473684	0.0310904860039121	0.104735829712641	1	1	0.977695870466275	0.980596180369174	0.893544552706841
down	PIK3C2G; PIK3R5; CDS1; PITPNM3;	GO:0006661~phosphatidylinositol biosynthetic process	4	76	5.26315789473684	0.0310904860039121	0.104735829712641	1	1	0.977695870466275	0.980596180369174	0.893544552706841
down	HSPB1; TLR8; TLR7;	GO:0001932~regulation of protein phosphorylation	3	44	6.81818181818182	0.0323191061536485	0.106619345561341	1	1	0.978714303664677	0.980596180369174	0.909613603108792
down	FOXE1; EPHB3; HES1;	GO:0048538~thymus development	3	44	6.81818181818182	0.0323191061536485	0.106619345561341	1	1	0.978714303664677	0.980596180369174	0.909613603108792
down	SDC1; ALDH3A1; DUOX1;	GO:0051591~response to cAMP	3	44	6.81818181818182	0.0323191061536485	0.106619345561341	1	1	0.978714303664677	0.980596180369174	0.909613603108792
down	TRPM2; TMC1; CACNG6; P2RY12; TRPV5;	GO:0070588~calcium ion transmembrane transport	5	115	4.34782608695652	0.0333063702715686	0.109749115929578	1	1	0.979802973635383	0.980596180369174	0.936314964729114
down	RBFOX2; FGFR3; ESRP1; ESRP2;	GO:0008543~fibroblast growth factor receptor signaling pathway	4	79	5.06329113924051	0.0349132723982084	0.113727787777688	1	1	0.980596180369174	0.980596180369174	0.970258654931793
down	TF; IGFBP2; IGFBP5; SPARCL1; VWA1; LMCD1; SNCAIP;	GO:0044267~cellular protein metabolic process	7	200	3.5	0.0352809521435193	0.114794138002971	1	1	0.980596180369174	0.980596180369174	0.979356128429577
down	BMP7; IGSF9; BAIAP2;	GO:0016358~dendrite development	3	46	6.52173913043478	0.0359420904448938	0.116413118881243	1	1	0.980596180369174	0.980596180369174	0.993168321913753
down	TAL1; SPI1; EPAS1;	GO:0030218~erythrocyte differentiation	3	46	6.52173913043478	0.0359420904448938	0.116413118881243	1	1	0.980596180369174	0.980596180369174	0.993168321913753
down	KCNQ1; MYBPC3; PPP1R13L;	GO:0060048~cardiac muscle contraction	3	46	6.52173913043478	0.0359420904448938	0.116413118881243	1	1	0.980596180369174	0.980596180369174	0.993168321913753
down	PLS3; SPNS2; SULF1;	GO:0060348~bone development	3	46	6.52173913043478	0.0359420904448938	0.116413118881243	1	1	0.980596180369174	0.980596180369174	0.993168321913753
down	LIPN; ASPG; LIPH; LIPG;	GO:0016042~lipid catabolic process	4	81	4.93827160493827	0.0376063636558348	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	SOX9; CCL26; CX3CL1; CCL24;	GO:0071347~cellular response to interleukin-1	4	81	4.93827160493827	0.0376063636558348	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	CEACAM6; CXADR; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.0378285709012879	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	HRH2; HRH1; NDRG4;	GO:0008542~visual learning	3	47	6.38297872340426	0.0378285709012879	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	BMP7; HHEX; ANXA1;	GO:0043434~response to peptide hormone	3	47	6.38297872340426	0.0378285709012879	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	KCNK1; KCNQ1; CACNG6;	GO:0061337~cardiac conduction	3	47	6.38297872340426	0.0378285709012879	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	CCND1; SOX9; TEAD4; TEAD3; WWTR1; NOTCH3;	GO:0006367~transcription initiation from RNA polymerase II promoter	6	161	3.72670807453416	0.0386075189176853	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	RHOD; ERBB2; MDK;	GO:0045785~positive regulation of cell adhesion	3	48	6.25	0.0397646628754909	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	HAS3; GCNT3; ME1; FUT2; B3GAT1;	GO:0005975~carbohydrate metabolic process	5	121	4.13223140495868	0.0397749841447337	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	RASSF9; ANXA8; CHMP4C; ANXA8L1;	GO:0016197~endosomal transport	4	83	4.81927710843374	0.0404154056944517	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	SNCG; NFASC; PCDHGC3;	GO:0050808~synapse organization	3	49	6.12244897959184	0.0417500485425121	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	GRHL2; PPP1R13L; WWTR1; ETNK2;	GO:0035264~multicellular organism growth	4	84	4.76190476190476	0.0418634356258869	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	PCDH7; F13A1; TF; ORM2; ECM1;	GO:0002576~platelet degranulation	5	124	4.03225806451613	0.0432757979584976	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	CDH1; SOX2; PHLDA2; TSKU; TMPRSS4; MECOM;	GO:0010468~regulation of gene expression	6	166	3.6144578313253	0.0435091870334927	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	FOXP2; DCN; MYH14;	GO:0007519~skeletal muscle tissue development	3	50	6	0.0437843856330293	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	CRYAB; SDC1; HBA1;	GO:0042542~response to hydrogen peroxide	3	50	6	0.0437843856330293	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	ELF3; HES1; TP63;	GO:0045747~positive regulation of Notch signaling pathway	3	50	6	0.0437843856330293	0.118605276781384	1	1	0.980596180369174	0.980596180369174	1
down	MNDA; NCKAP1L; BCAR1; IGHV4-61; IGHV4-59;	GO:0050853~B cell receptor signaling pathway	5	125	4	0.0444825345675904	0.120267593460522	1	1	0.980596180369174	0.980596180369174	1
down	KCNK1; KCNQ1; P2RY12; KCNH7; SLC9A3;	GO:0071805~potassium ion transmembrane transport	5	125	4	0.0444825345675904	0.120267593460522	1	1	0.980596180369174	0.980596180369174	1
down	EPHA2; EFNB2; EPHB3; NGEF;	GO:0048013~ephrin receptor signaling pathway	4	86	4.65116279069767	0.0448464791862653	0.120390364177083	1	1	0.980596180369174	0.980596180369174	1
down	TERT; CAV2; CXADR; EPAS1;	GO:0007005~mitochondrion organization	4	88	4.54545454545455	0.0479453402112626	0.127950869718854	1	1	0.980596180369174	0.980596180369174	1
down	GABRP; GABRE; CHRNG;	GO:0050877~nervous system process	3	52	5.76923076923077	0.0479984295257239	0.127950869718854	1	1	0.980596180369174	0.980596180369174	1
down	SDC4; GPR65; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	3	52	5.76923076923077	0.0479984295257239	0.127950869718854	1	1	0.980596180369174	0.980596180369174	1
